Fondaparinux Sodium Injection — FDA Drug Shortage

No longer listed by FDA — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

The FDA lists a drug shortage record for Fondaparinux Sodium Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status No longer listed by FDA. The shortage was first posted on Sep 29, 2025.

Shortage details

Status
No longer listed by FDA
Company
Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Package NDC
0781-3454-95
Dosage Form
Injection
Presentation
Fondaparinux Sodium, Injection, 5 mg/.4 mL (NDC 0781-3454-95)
Initial Posting
Sep 29, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.